DBV Technologies | Crediti Commerciali



Trade Debtors Cambiamento Data
Acadia Pharmaceuticals USD 104.7M 5.67M 2024-12
Alnylam Pharmaceuticals USD 405.31M 51.46M 2024-12
Amarin USD 112.64M 11.05M 2024-09
BioMarin Pharmaceutical USD 660.54M 117.01M 2024-12
DBV Technologies USD 20.1M 553K 2024-09
Halozyme Therapeutics USD 308.46M 22.71M 2024-12
Incyte USD 853.15M 94.7M 2024-12
Insmed USD 52.01M 9.7M 2024-12
Ionis Pharmaceuticals USD 92.19M 74.26M 2024-12
Neurocrine Biosciences USD 479.1M 2M 2024-12
PTC Therapeutics USD 158.55M 41.42M 2024-12
Sarepta Therapeutics USD 649.73M 133.74M 2024-12
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
United Therapeutics USD 279.3M 62.5M 2024-12



DBV Technologies Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.